Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEAT Study: ThermoDox + RFA in HCC
NCT00617981Phase 3Completed
- Sponsor
- Imunon, Inc.
- Start
- May 2008
- Primary completion
- Jan 2013
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of ThermoDox in hepatocellular carcinoma (HCC), sponsored by Imunon, Inc.. Started May 2008; status: completed.
02
Drugs
ThermoDox
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00617981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00617981.